Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,68 USD | +1,83% | -5,52% | +101,20% |
27/03 | RANI THERAPEUTICS HOLDINGS, INC. : Canaccord Genuity ancora positivo | ZM |
25/03 | RANI THERAPEUTICS HOLDINGS, INC. : HC Wainwright conferma il rating Buy | ZM |
Attività
Numero di dipendenti: 140
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 01/06/21 |
Mir Imran
FOU | Founder | 68 | 06/04/21 |
Svai Sanford
DFI | Director of Finance/CFO | 53 | 06/04/21 |
Jacques Van Dam
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Mir Hashim
CTO | Chief Tech/Sci/R&D Officer | 65 | 06/04/21 |
Bella Vazquez
HRO | Human Resources Officer | - | 01/07/21 |
Eric Groen
LAW | General Counsel | - | 09/09/21 |
Kate McKinley
PRN | Corporate Officer/Principal | - | 24/05/23 |
Arvinder Dhalla
PRN | Corporate Officer/Principal | - | 01/07/21 |
General Counsel | - | 01/07/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 06/04/21 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 06/04/21 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 06/04/21 |
Mir Imran
FOU | Founder | 68 | 06/04/21 |
Director/Board Member | 65 | 06/04/21 | |
Talat Imran
CEO | Chief Executive Officer | 43 | 01/06/21 |
Maulik Nanavaty
BRD | Director/Board Member | 62 | 06/04/21 |
Mir Hashim
CTO | Chief Tech/Sci/R&D Officer | 65 | 06/04/21 |
Lisa Rometty
BRD | Director/Board Member | - | 03/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 10 | 24 116 444 | 0 | 0 | 25,63 % |
Azione B | 1 | 29 298 553 | 13 690 556 ( 46,73 %) | 3 000 000 ( 10,24 %) |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+101,20% | 176 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione RANI
- Società Rani Therapeutics Holdings, Inc.